Personalizing Functional Assessment in Chronic Obstructive Pulmonary Disease: A Validation Study of the Patient-Specific Functional Scale

<b>Background</b>: Personalized and accurate assessment of functional performance in chronic obstructive pulmonary disease (COPD) requires patient-centered tools that capture individualized activity limitations. The Patient-Specific Functional Scale (PSFS) is brief and clinically accessible, but its psychometric properties in COPD have not been fully established. This study aimed to evaluate the reliability and construct validity of the PSFS in individuals with COPD. <b>Methods</b>: A longitudinal psychometric evaluation was conducted with 70 adults diagnosed with COPD confirmed by spirometry. The PSFS was administered twice, 4-7 days apart, to examine test-retest reliability, standard error measurement (SEM), and minimal detectable change at 95% confidence interval (MDC<sub>95%</sub>). Construct validity was assessed through correlations between the PSFS, the Duke Activity Status Index (DASI), and the St. George's Respiratory Questionnaire (SGRQ). Floor and ceiling effects were also evaluated. <b>Results</b>: Seventy participants (mean age 63 ± 11 years) completed the study. The PSFS demonstrated excellent test-retest reliability (ICC = 0.94; 95% CI: 0.90-0.96), and low SEM (0.16 points), and the MDC<sub>95%</sub> was 0.44 points, with no floor or ceiling effects. Construct validity was supported by moderate positive correlations with DASI (r = 0.51, <i>p</i> < 0.001) and moderate negative correlations with SGRQ total scores (r = -0.41, <i>p</i> < 0.001). PSFS scores were not associated with demographic variables or COPD severity. <b>Conclusions</b>: The PSFS demonstrates strong psychometric properties in COPD, including excellent reliability and moderate construct validity. Its individualized approach, ease of administration, and ability to capture functional limitations beyond traditional clinical measures support its utility in both clinical practice and research for personalized functional assessment.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-12-20
DOI
https://doi.org/10.3390/jcm15010037
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Personalizing Functional Assessment in Chronic Obstructive Pulmonary Disease: A Validation Study of the Patient-Specific Functional Scale

Rakan I. Nazer, Ali Albarrati, Asma Alonazi, Monira Ibrahim Aldhahi
Journal of Clinical Medicine
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Personalizing Functional Assessment in Chronic Obstructive Pulmonary Disease: A Validation Study of the Patient-Specific Functional Scale

Rakan I. Nazer, Ali Albarrati, Asma Alonazi, Monira Ibrahim Aldhahi
article en

Abstract

<b>Background</b>: Personalized and accurate assessment of functional performance in chronic obstructive pulmonary disease (COPD) requires patient-centered tools that capture individualized activity limitations. The Patient-Specific Functional Scale (PSFS) is brief and clinically accessible, but its psychometric properties in COPD have not been fully established. This study aimed to evaluate the reliability and construct validity of the PSFS in individuals with COPD. <b>Methods</b>: A longitudinal psychometric evaluation was conducted with 70 adults diagnosed with COPD confirmed by spirometry. The PSFS was administered twice, 4-7 days apart, to examine test-retest reliability, standard error measurement (SEM), and minimal detectable change at 95% confidence interval (MDC<sub>95%</sub>). Construct validity was assessed through correlations between the PSFS, the Duke Activity Status Index (DASI), and the St. George's Respiratory Questionnaire (SGRQ). Floor and ceiling effects were also evaluated. <b>Results</b>: Seventy participants (mean age 63 ± 11 years) completed the study. The PSFS demonstrated excellent test-retest reliability (ICC = 0.94; 95% CI: 0.90-0.96), and low SEM (0.16 points), and the MDC<sub>95%</sub> was 0.44 points, with no floor or ceiling effects. Construct validity was supported by moderate positive correlations with DASI (r = 0.51, <i>p</i> < 0.001) and moderate negative correlations with SGRQ total scores (r = -0.41, <i>p</i> < 0.001). PSFS scores were not associated with demographic variables or COPD severity. <b>Conclusions</b>: The PSFS demonstrates strong psychometric properties in COPD, including excellent reliability and moderate construct validity. Its individualized approach, ease of administration, and ability to capture functional limitations beyond traditional clinical measures support its utility in both clinical practice and research for personalized functional assessment.

Journal of Clinical MedicineVol. 15(1)
Princess Nourah bint Abdulrahman University (SA), Majmaah University (SA), King Saud University (SA)
Princess Nourah Bint Abdulrahman University
Openalex Percentile: Top 29%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.